UMIN-ICDS History

Name：　　UMIN ID：

Unique ID issued by UMIN	UMIN000062375
Receipt number	R000071329
Scientific Title	A multicenter prospective observational study evaluating the efficacy and safety of amivantamab plus lazertinib in patients with EGFR (exon19 deletion or L858R)-mutated advanced or recurrent NSCLC previously treated with osimertinib (with or without chemotherapy)
Date of disclosure of the study information	2026/07/28
Last modified on	2026/07/28 18:17:01

---